| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 05/08/2003 | US20030087948 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use |
| 05/08/2003 | US20030087945 Sulfonylaminocarboxylic acids |
| 05/08/2003 | US20030087939 Novel succinate derivative compounds useful as cysteine protease inhibitors |
| 05/08/2003 | US20030087932 Sulfuric acid mono-[ 3- ( {1- [ 2- (4-fluoro-phenyl ) -ethyl ] -piperidin-4-YL} -hydroxy-methyl) -2-methoxy-phenyl ] ester |
| 05/08/2003 | US20030087903 Mevinolin derivatives |
| 05/08/2003 | US20030087890 Substituted carbocyclic or heterocyclic hydroxamic acid derivatives, e.g., (3R,4S)-N-hydroxy-1-methyl-3-(((4-((2-methyl-4 -quinolinyl)methoxylphenyl)sulfonyl)methyl)-4-piperidinecarboxamide |
| 05/08/2003 | US20030087832 Anticancer agents; antidiabetic agents, anticholesterol agents, cardiovascular disorders, osteoporosis |
| 05/08/2003 | US20030087306 Methods for identifying novel multimeric agents that modulate receptors |
| 05/08/2003 | US20030086666 Novel nonlinear optical polymers incorporating amines |
| 05/08/2003 | US20030085388 Novel nonlinear optical compounds and polymers |
| 05/08/2003 | CA2468761A1 Novel anticancer compounds |
| 05/08/2003 | CA2465429A1 Compounds and method for the treatment of overactive bladder |
| 05/08/2003 | CA2462206A1 Substituted thioacetamides |
| 05/07/2003 | EP1308440A1 Piperidine derivatives and drugs containing these derivatives as the active ingredient |
| 05/07/2003 | EP1307579A2 Bio-intermediates for use in the chemical synthesis of polyketides |
| 05/07/2003 | EP1307449A1 1,4-dihydropyridines as bradykinin antagonists |
| 05/07/2003 | EP1307423A1 New processes for the production of fexofenadine |
| 05/07/2003 | EP1307196A1 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation |
| 05/07/2003 | EP1307194A1 Fentanyl composition for nasal administration |
| 05/07/2003 | EP0912510B1 Nickel catalyzed addition of -nh- containing compounds to vinyl and aryl halides |
| 05/07/2003 | EP0885190B1 N-substituted 4-((4'-aminobenzoyl)-oxymethyl)-piperidines having gastric prokinetic properties |
| 05/07/2003 | EP0869791B1 4-substituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
| 05/07/2003 | EP0751765B1 Sulfonamide derivatives and their use |
| 05/07/2003 | CN1415606A Method of preparing compound of 0-substituted sulphonyl propylhomoserin class |
| 05/06/2003 | US6559312 Intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 05/06/2003 | US6559185 Nitromethyl ketone compounds having aldose reduction inhibiting properties and methods for their use |
| 05/06/2003 | US6559166 A class of phenylsulphonyl derivatives wherein the sulphonyl moiety is also attached to an N-arylalkyl-substituted azetidine, pyrrolidine or piperidine ring are selective antagonists of the human 5-HT2A receptor and are therefore |
| 05/06/2003 | US6559165 Prevention, treatment, or management of apnea, apnea disorders, bulimia nervosa, irritable bowel syndrome, urinary incontinence, bradycardia, bradyarrhythmia, syncope, other disorders, or symptoms thereof using (-) norcisapride, or salt |
| 05/06/2003 | US6559146 Neuroprotective effects by inducing calbindin D28Kd, one of Ca2+-binding proteins |
| 05/06/2003 | US6558931 Generation of preferential compounds; obtain chemical intermediates, incubate with microorganisms, isolating or purifying compound |
| 05/06/2003 | CA2036905C Condensed thiazole compounds, their production and use |
| 05/02/2003 | EP1306371A1 Cyclic imines |
| 05/02/2003 | EP1305304A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 05/02/2003 | EP1305287A1 ENANTIOMER SEPARATION OF PIPERIDONE DERIVATIVES WITH SIMULTANEOUS i IN SITU /i RACEMIZATION OF THE UNWANTED ENANTIOMER |
| 05/02/2003 | EP1305021A1 Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition |
| 05/02/2003 | EP0918761B1 Certain amido- and amino-substituted benzylamine derivatives; a new class of neuropeptite y1 specific ligands |
| 05/02/2003 | EP0910563B1 Integrin receptor antagonists |
| 05/02/2003 | EP0831799B1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders |
| 05/02/2003 | EP0786988B1 Use of nk1 receptor antagonists for preparing cardio-regulatory drugs |
| 05/01/2003 | WO2003035745A1 Blends of waxes and polymer additives |
| 05/01/2003 | WO2003035645A1 Novel 4-(2-furoyl)aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same |
| 05/01/2003 | WO2003035623A1 Method of resolving amlodipine racemate |
| 05/01/2003 | WO2003035057A1 Inhibitors of dipeptidyl peptidase iv |
| 05/01/2003 | WO2002079186A3 Aminopiperidine derivatives as modulators of chemokine receptor activity |
| 05/01/2003 | WO2002046158A9 Piperidine/piperazine-type inhibitors of p38 kinase |
| 05/01/2003 | US20030083504 N- (4-carbamimidoyl-phenyl) -glycine derivatives |
| 05/01/2003 | US20030083502 Preparation of 4-haloalkylnicotinic esters |
| 05/01/2003 | US20030083498 Compounds, oligomers and polylactams as protectorants against ultraviolet radiation; also oxidation and heat resistance; discoloration inhibition; weatherproofing; molding materials; coatings; films; auto under- and overcoatings |
| 05/01/2003 | US20030083406 4-Formyl amino-n-methylpiperidine derivatives, the use thereof as stabilisers and organic material stabilised therewith |
| 05/01/2003 | US20030083355 Novel crude and crystalline forms of lercanidipine hydrochloride |
| 05/01/2003 | US20030083333 1,4-Disubstituted benzo-fused compounds |
| 05/01/2003 | US20030080318 Inhibition of polymerization of unsaturated monomers |
| 05/01/2003 | CA2466806A1 Method of resolving amlodipine racemate |
| 05/01/2003 | CA2464254A1 Inhibitors of post-proline cleaving proteases |
| 04/30/2003 | CN1414849A Carboxylic acid amides, medicaments containing these compounds and the use and preparation thereof |
| 04/30/2003 | CN1107061C Chemotaxis cell factor receptor-3 receptor antagonists |
| 04/29/2003 | US6555689 Intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 04/29/2003 | US6555556 N-(4-(1-acetimidoylpiperidin-4-yl)oxyphenyl)-N-((E)-3-(3 -amidinophenyl)-2-methyl-2-propenyl)sulfamoylacetic acid dihydrochloride for example; factor Xa inhibitors |
| 04/29/2003 | US6555548 Administering therapeutically effective amount of active agent selected from the group consisting of a heterocyclic amine-type compound, a substituted phenylazacycloalkane-type compound, and a cabergoline-type compound, and their salts |
| 04/29/2003 | US6555542 Sulfonamide lactam inhibitors of FXa and method |
| 04/29/2003 | US6555541 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions |
| 04/24/2003 | WO2003033490A1 Synthesis of 4-[(z)-(4-bromophenyl)(ethoxyimino)methyl]-1'-[2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl]-4'methyl-1,4'bipiperidine |
| 04/24/2003 | WO2003033489A1 Piperidine derivatives, process for preparation thereof, and pharmaceutical composition for alzheimer's disease containing the same |
| 04/24/2003 | WO2003033487A1 Piperidine- and piperazineacetamines as 17beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 04/24/2003 | WO2003033466A1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 04/24/2003 | WO2003033465A1 Synthesis of (4-bromophenyl) (4-piperidyl)methanone-(z)-o-ethyloxime and salts |
| 04/24/2003 | WO2003032980A1 5'-carbamoyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032912A2 Treatment of cns disorders using cns target modulators |
| 04/24/2003 | WO2003032910A2 Carbinols for the treatment of neuropathic dysfunction |
| 04/24/2003 | WO2003032894A2 Method of monitoring neuroprotective treatment |
| 04/24/2003 | WO2002098850A3 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 04/24/2003 | WO2002059090A3 Oligomeric hindered amine light stabilizers based on multi-functional carbonyl compounds and methods of making same |
| 04/24/2003 | WO2002058690A3 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
| 04/24/2003 | US20030078440 O- or S- substituted tetrahydronaphthalene derivatives useful as regulators of cell proliferation and differentiation, useful for treating skin-related diseases |
| 04/24/2003 | US20030078438 N-heterocyclicamide compounds; used as anticoagulant agent |
| 04/24/2003 | US20030078430 Process for preparing 1,4-dihydropyridine compounds |
| 04/24/2003 | US20030078429 Diastereomeric salt between (R)-(+)- alpha -(4-(1,1-dimethylethyl or dimethylacetic acid or ester )phenyl)-4-hydroxydiphylphenylmethyl)-1 pipridinebutanol and either mandelic acid or di-para-toluoyltartaric acid |
| 04/24/2003 | US20030078428 Phenylamino benzhydroxamic acid derivatives inhibit certain dual specificity kinase enzymes involved in proliferative diseases such as cancer, psoriasis and restenosis; inhibit the phosphorylation of MAP kinase by MEK |
| 04/24/2003 | US20030078427 Monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 04/24/2003 | US20030078425 N-oxyl compound contained in an easily polymerizable material can be sufficiently decreased and loss of easily polymerizable material (acrylic or methacrylic acids or their esters) is little |
| 04/24/2003 | US20030078282 For therapy of allergic dermatitis and atopy in animals and humans |
| 04/24/2003 | US20030078253 Matrix metalloprotease inhibitors |
| 04/24/2003 | US20030078250 Diphenyl urea compounds for treating a chemokine mediated disease; interleukin-8 (il-8) |
| 04/24/2003 | US20030078249 VLA-4 inhibitor compounds |
| 04/24/2003 | US20030078241 Treating effects of excessive reactive oxygen species |
| 04/24/2003 | CA2463579A1 Treatment of cns disorders using cns target modulators |
| 04/24/2003 | CA2463518A1 Carbinols for the treatment of neuropathic dysfunction |
| 04/24/2003 | CA2463511A1 Synthesis of 4-[(z)-(4-bromophenyl)(ethoxyimino)methyl]-1'-[2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl]-4'methyl-1,4'bipiperidine |
| 04/23/2003 | EP1304324A1 Serotonin reuptake inhibitors |
| 04/23/2003 | EP1304322A2 Carboxylic acid compound and use thereof |
| 04/23/2003 | EP1303513A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases |
| 04/23/2003 | EP1303503A2 Aniline derivatives |
| 04/23/2003 | EP1303489A2 Alpha,alpha-dibromo-alpha-chloro-acetophenones as synthons |
| 04/23/2003 | EP1303488A1 Piperidine compounds for use as ccr-3 inhibitors |
| 04/23/2003 | EP1303482A2 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives |
| 04/23/2003 | EP1154794B1 Treatment of symptoms of parkinson's disease with an agent comprising a dopaminergic substance and a local anaesthetic of the anilide group |
| 04/23/2003 | EP1063230B1 Cyclic amino compounds |
| 04/23/2003 | EP0993442B1 Hydrazine derivatives |
| 04/23/2003 | EP0937041B1 Use of a pharmaceutically acceptable salt of (3R,2'R)-3-[(Cyclopently-hydroxyphenylacetyl)oxy]-1,1-dimethyl-pyrrolidinium for the preparation of a medicament |
| 04/23/2003 | EP0882712B1 Process for preparing acid salts of gamma-(piperidyl)butyric acid |